Form 4: Liquidia Corp Executive Sells Shares to Cover Taxes on RSU Settlement

Liquidia Corp's Chief Commercial Officer, Scott Moomaw, sold 1,585 shares of common stock on April 12, 2024, to cover taxes associated with the settlement of restricted stock units.

Summary

• On April 12, 2024, Scott Moomaw, Chief Commercial Officer of Liquidia Corp, sold 1,585 shares of Liquidia Corp [LQDA] common stock.
• The sale was executed at a price of $14.58 per share.
• The transaction was made pursuant to a Rule 10b5-1 plan adopted on December 15, 2023.
• The shares were sold to cover taxes associated with the settlement of restricted stock units (RSUs) that were initially granted on January 11, 2023.
• Following the transaction, Moomaw still beneficially owns 151,881 shares, which includes unvested RSUs and shares acquired under the employee stock purchase plan.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine transaction related to executive compensation and tax obligations. There's no indication of positive or negative implications for the company's performance.

Industry Context

Sales of shares to cover tax obligations upon vesting of restricted stock units are a common practice among corporate executives and are generally viewed as a normal part of executive compensation.

Comparison to Industry Standards

• Executive compensation practices, including the use of RSUs and subsequent stock sales to cover taxes, are standard across publicly traded companies, particularly in the pharmaceutical and biotechnology sectors.
• Companies like United Therapeutics, Vertex Pharmaceuticals, and BioMarin Pharmaceutical also utilize equity-based compensation, and their executives often engage in similar transactions.
• The use of Rule 10b5-1 plans is a common method to avoid accusations of insider trading, aligning with industry best practices for managing executive stock transactions.

Key Dates